Gain Therapeutics (GANX) Intangibles (2021 - 2026)

Gain Therapeutics has reported Intangibles for 6 years, with the latest figure at $76782.0 in Q2 2026.

• On a quarterly basis, Intangibles fell 39.95% year-over-year to $76782.0 in Q2 2026; TTM through Jun 2026 was $76782.0, a 39.95% decrease from a year earlier, with the FY2025 full-year figure at $102837.0, down 23.41% from the prior year.
• Intangibles was $76782.0 for Q2 2026 at Gain Therapeutics, down from $90045.0 in the prior quarter.
• The five-year high for Intangibles was $213967.0 in Q4 2022, with the low at $76782.0 in Q2 2026.
• Average Intangibles over 5 years is $157818.8, with a median of $158149.0 recorded in 2024.
• The sharpest annual moves came in 2022 and 2026: Intangibles grew 5.61% in 2022, then plunged 39.95% in 2026.
• Over 5 years, Intangibles stood at $213967.0 in 2022, then declined by 9.62% to $193375.0 in 2023, then tumbled by 30.57% to $134268.0 in 2024, then dropped by 23.41% to $102837.0 in 2025, then fell by 25.34% to $76782.0 in 2026.
• The last three Intangibles figures came in at $76782.0 (Q2 2026), $90045.0 (Q1 2026), and $102837.0 (Q4 2025), per Business Quant data.